Distinctive grade based on Ki67 index and immune microenvironment of metastatic pancreatic neuroendocrine tumors responding to capecitabine plus temozolomide

Abstract Background Ki67 index changes during the treatment of metastatic pancreatic neuroendocrine tumor (PanNET) treatment. The study aimed to detect alterations of grade based on Ki67 index and immune microenvironment in PanNET responding to capecitabine/temozolomide (CapTem). Method Retrospectiv...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Heli Gao, Wuhu Zhang, Zheng Li, Wensheng Liu, Mengqi Liu, Qifeng Zhuo, Yihua Shi, Wenyan Xu, Chenjie Zhou, Yi Qin, Jin Xu, Jie Chen, Xianjun Yu, Xiaowu Xu, Shunrong Ji
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMC 2024-11-01
Serie:	BMC Cancer
Soggetti:	Pancreatic neuroendocrine tumor Ki67 index Capecitabine/temozolomide Upgrading Tumor microenvironment
Accesso online:	https://doi.org/10.1186/s12885-024-13117-5
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!